| 31/01 | Zai Lab Announces Participation in February Investor Conferences |  |
| 31/01 | Zai Lab Announces Participation in February Investor Conferences | |
| 30/01 | Zai Lab Says Chinese Regulator Grants Priority Review to New Drug Application for Sulba.. | |
| 30/01 | Zai Lab Announces NDA for Sulbactam-Durlobactam (SUL-DUR) Granted Priority Review by Ch.. | |
| 30/01 | Zai Lab Announces NDA for Sulbactam-Durlobactam (SUL-DUR) Granted Priority Review by Ch.. | |
| 30/01 | Zai Lab Limited Announces New Drug Application for Sulbactam-Durlobactam (SUL-DUR) Gran.. | |
| 19/01 | Two Zai Lab Drugs Added to China's National Reimbursement Drug List | |
| 18/01 | Zai Lab's Qinlock, Nuzyra Added to China's National Reimbursement Drug List; Shares Ris.. | |
| 18/01 | Paratek Pharmaceuticals Says Nuzyra Added to China's National Reimbursement Drug List | |
| 18/01 | Zai Lab Limited Announces Executive Appointments | |
| 18/01 | Zai Lab's Qinlock, Nuzyra Listed Among China's National Reimbursement Drugs | |
| 18/01 | Zai Lab Announces Inclusion of QINLOCK® (ripretinib) and NUZYRA® (omadacycline) in Chin.. | |
| 18/01 | Zai Lab Announces Inclusion of QINLOCK® (ripretinib) and NUZYRA® (omadacycline) in Chin.. | |
| 18/01 | Zai Lab Limited Announces Inclusion of QINLOCK® and NUZYRA® (omadacycline) in China.. | |
| 09/01 | Zai Lab Ltd : Change in Directors or Principal Officers, Financial Statements and Exhibits.. | |
| 09/01 | Zai Lab Appoints Michel Vounatsos To Its Board of Directors | |
| 09/01 | Zai Lab Appoints Michel Vounatsos To Its Board of Directors | |
| 09/01 | Zai Lab Limited Appoints Michel Vounatsos to the Board of Directors | |
| 06/01 | Tumor Treating Fields Study by Zai Lab’s Partner in Cancer Patients Reaches Prima.. | |
| 06/01 | ADR Shares End Mostly Lower; Zai Lab, HSBC Trade Actively | |
| 05/01 | Health Care Edge Lower Amid Drug-Development Hopes -- Health Care Roundup | |
| 05/01 | Zai Lab Ltd : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 05/01 | Sector Update: Health Care Stocks Nudge Above Thursday Intra-Day Lows | |
| 05/01 | Sector Update: Health Care Stocks Struggling Thursday but Biotech Edging H.. | |
| 05/01 | Top Midday Gainers | |
| 05/01 | Financial Stocks Weigh Down Asian Equities in Thursday Trading | |
| 05/01 | NovoCure, Zai Lab Study in Non-Small Cell Lung Cancer Meets Primary Endpoint'; Shares C.. | |
| 05/01 | NovoCure, Zai Lab Say Study of Non-Small Cell Lung Cancer Treatment Meets Primary Endpo.. | |
| 05/01 | Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Pri.. | |
| 05/01 | Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Pri.. | |
| 05/01 | Zai Lab Limited and Novocure Announce Pivotal Lunar Study in Non-Small Cell Lung Cancer.. | |
| 03/01 | Zai Lab Announces the Appointment of Dr. Rafael G. Amado as President, Head of Global O.. | |
| 03/01 | Zai Lab Limited Announces the Appointment of Dr. Rafael G. Amado as President, Head of .. | |
| 03/01 | Zai Lab Grants Share Options, Restricted Share Units | |
| 2022 | Rebounding US stocks Help Boost American Depositary Receipts of Asian Equities | |
| 2022 | Solar Stocks Weigh on Asian Equities in Friday Trading | |
| 2022 | Zai Lab : Statement Regarding the PCAOB's Conclusion That It Has Complete Access to Inspec.. | |
| 2022 | Zai Lab Announces Participation in January Investor Conferences | |
| 2022 | Zai Lab Announces Participation in January Investor Conferences | |
| 2022 | Zai Lab Presents Interim Overall Survival Data for ZEJULA® (niraparib) from the NORA Ph.. | |
| 2022 | Zai Lab Presents Interim Overall Survival Data for ZEJULA® (niraparib) from the NORA Ph.. | |
| 2022 | Zai Lab Limited Presents Interim Overall Survival Data for ZEJULA® from the NORA Phase .. | |
| 2022 | Zai Lab Grants 108,000 American Depositary Shares | |
| 2022 | Insider Sell: Zai Lab | |
| 2022 | Zai Lab Partner Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurren.. | |
| 2022 | Zai Lab Partner Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurren.. | |
| 2022 | Asian Equities Decline Despite Reports China Will Further Ease COVID Restrictions | |
| 2022 | Zai Lab : to Present Interim Overall Survival Results for ZEJULA® (niraparib) from the Pha.. | |
| 2022 | Hopes of Easing COVID Restrictions Boost Asian Equities | |
| 2022 | Asian Equities Diverge From US Markets, Climb in Thursday Trading | |
| 2022 | Zai Lab Grants American Depositary Shares | |
| 2022 | Asian ADRs Surge Higher in Friday Trading as China Eases COVID-19 Restrictions | |
| 2022 | Asian ADRs Soar in Thursday Trading Following US Inflation Data | |
| 2022 | Zai Lab's Q3 Net Loss Widens | |
| 2022 | Zai Lab Reports Wider Q3 Loss, Higher Revenue | |
| 2022 | ZAI LAB LTD Management's Discussion and Analysis of Financial Condition and Results
of.. | |
| 2022 | Zai Lab Limited Reports Earnings Results for the Third Quarter and Nine Months Ended Se.. | |
| 2022 | Earnings Flash (ZLAB) ZAI LAB LIMITED Posts Q3 Revenue $57.5M | |
| 2022 | Zai Lab Announces Third Quarter 2022 Financial Results and Corporate Updates | |
| 2022 | Zai Lab to Present New Oncology Research at 2022 Society for Immunotherapy of Cancer An.. | |
| 2022 | Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer | |
| 2022 | Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer | |
| 2022 | Zai Lab Limited Announces the Appointment of Peter Huang as Chief Scientific Officer | |
| 2022 | Asian ADRs Move Slightly Higher in Wednesday Trading | |
| 2022 | Asian ADRs Surge Higher in Tuesday Trading | |
| 2022 | Zai Lab Announces Participation in November Investor Conferences | |
| 2022 | Zai Lab Announces Participation in November Investor Conferences | |
| 2022 | Zai Lab Ltd : Change in Directors or Principal Officers (form 8-K) | |
| 2022 | Asian ADRs Move Lower in Friday Trading | |
| 2022 | Asian ADRs Move Lower in Thursday Trading | |
| 2022 | Asian ADRs Move Higher in Tuesday Trading | |
| 2022 | Asian ADRs Tumble in Monday Trading | |
| 2022 | Asian ADRs Move Lower in Friday Trading | |
| 2022 | Asian ADRs Move Lower in Tuesday Trading | |
| 2022 | Zai Lab to Announce Third Quarter 2022 Financial Results on November 9, 2022 | |
| 2022 | Zai Lab Launches its first Trust Report | |
| 2022 | Zai Lab Launches its first Trust Report | |
| 2022 | Zai Lab Grants Share Options Under Equity Incentive Scheme | |
| 2022 | Zai Lab's H1 Loss Narrows to $220 Million; Shares Slip 6% | |
| 2022 | Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for .. | |
| 2022 | Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for .. | |
| 2022 | Zai Lab Strikes Licensing Deal with Nasdaq-listed Seagen for Cervical Cancer Drug | |
| 2022 | Zai Lab Signs Exclusive Collaboration, License Agreement With Seagen to Develop, Commer.. | |
| 2022 | Zai Lab : Corporate Presentation | |
| 2022 | Zai Lab Ltd : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financ.. | |
| 2022 | Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for .. | |
| 2022 | Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for .. | |
| 2022 | Asian ADRs Move Lower in Wednesday Trading | |
| 2022 | Zai Lab to Present Analysis of the Impact of Timing for ZEJULA® (niraparib) Maintenance.. | |
| 2022 | Zai Lab to Present Analysis of the Impact of Timing for ZEJULA® (niraparib) Maintenance.. | |
| 2022 | Zai Lab to Present Analysis of the Impact of Timing for ZEJULA® Maintenance Treatment i.. | |
| 2022 | DRI Healthcare Trust Acquires Royalty Interest in Zejula, Currently Approved for Treatm.. | |
| 2022 | Asian ADRs Climb Sharply Higher in Friday Trading | |
| 2022 | US, China Reach Audit Deal to Prevent Delistings | |
| 2022 | Zai Lab : Updated Statement on SEC Listing Matter | |
| 2022 | Zai Lab Announces Participation in September Investor Conferences | |
| 2022 | Zai Lab : Argenx Announces European Commission Approval of VYVGART™ (efgartigimod al.. | |
| 2022 | Asian ADRs Move Sharply Higher in Wednesday Trading | |
| 2022 | Zai Lab : Corporate Presentation | |
| 2022 | Zai Lab Narrows Q2 Loss as Revenue Jumps 30%; Shares Slide 6% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Reporte
